CD8A and neoplasm: Anti-PD-1 mainly induces an increase in specific tumor-infiltrating exhausted-like CD8 T-cell populations, while anti-CTLA-4 predominantly induces the expansion of an ICOS+ Th1-like CD4 effector cell subset and binds to specific subsets of exhausted-like CD8 T cells (21).